HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of preoperative use of oral dextromethorphan on postoperative need for analgesics in patients with knee arthroscopy.

AbstractBACKGROUND:
Studies have shown that N-methyl-D-aspartate receptor (NMIDA) plays an essential role in postoperative pain. It seems that use of NMDA receptor antagonists such as Dextromethorphan intensifies the analgesic effects of opioids.
OBJECTIVES:
In this study, we evaluated the effect of preoperative administration of Dextromethorphan on postoperative pain reduction.
PATIENTS AND METHODS:
This double blind randomized clinical trial was conducted on arthroscopic surgery candidates. Participants were randomly allocated to interventions and assigned to two groups of Dextromethorphan and placebo. In Dextromethorphan group, the patients received 1 mg/kg Dextromethorphan orally the night before the operation. Pain severity based on the visual analog scale (VAS) up to 16 hours postoperation, use of opioids, and the first request for analgesics were recorded postoperatively.
RESULTS:
A total of 112 patients in the Dextromethorphan (n = 54) and placebo groups (n = 58) were evaluated. No significant difference was detected between the two groups for age, sex or ASA. The mean amount of opioid consumption was significantly lower in patients who received Dextromethorphan (10.7 ± 5.6 mg) compared to the placebo group (13.1 ± 5.6 mg), (P = 0.03). The mean time until the first opioid request in patients who received Dextromethorphan was longer than that in the placebo group (P = 0.01).
CONCLUSIONS:
The study results demonstrated that preemptive use of Dextromethorphan reduced postoperative pain and opioid consumption.
AuthorsSaeid Reza Entezary, Saeedeh Farshadpour, Mahmood Reza Alebouyeh, Farnad Imani, Mohammad Kazem Emami Meybodi, Habibollah Yaribeygi
JournalAnesthesiology and pain medicine (Anesth Pain Med) Vol. 4 Issue 1 Pg. e11187 (Feb 2014) ISSN: 2228-7523 [Print] Netherlands
PMID24660143 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: